{"id":7237,"date":"2025-07-02T18:20:55","date_gmt":"2025-07-02T23:20:55","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=7237"},"modified":"2025-07-13T15:09:02","modified_gmt":"2025-07-13T20:09:02","slug":"nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001ASGCT 2025\u5e74\u6b21\u7dcf\u4f1a\u3067\u753b\u671f\u7684\u306a\u7814\u7a76\u3092\u767a\u8868"},"content":{"rendered":"<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"row\">\n<div class=\"col-sm-12\">\n<div class=\"row detail-headline\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<h2 class=\"prntac\" style=\"text-align: center;\"><i>\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3067\u306f\u3001Nanoscope\u793e\u306e\u5149\u907a\u4f1d\u5b66\u7642\u6cd5\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306e\u8010\u4e45\u6027\u3001\u6709\u52b9\u6027\u3001\u5b89\u5168\u6027\u306b\u3064\u3044\u3066\u91cd\u70b9\u7684\u306b\u53d6\u308a\u4e0a\u3052\u307e\u3059\u3002<\/i><\/h2>\n<\/div>\n<div class=\"col-sm-4 col-xs-12 col-vcenter\">\n<div class=\"image logo logo-wrapper\" data-src=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=publish\" data-asset-type=\"photo\" data-asset-label=\"Logo\" data-download-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg\" data-tweet-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-pinterest-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-linkedin-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-facebook-share-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-twitter-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=twitter\" data-facebook-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=facebook\" data-pinterest-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=publish\" data-linkedin-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=linkedin\">\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">\u30c0\u30e9\u30b9<\/span><\/span>,\u00a0<span class=\"legendSpanClass\"><span class=\"xn-chron\">2025\u5e745\u670812\u65e5<\/span><\/span>\u00a0\/PRNewswire\/ \u2014\u00a0<a href=\"http:\/\/nanostherapeutics.com\/ja\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>, \u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u65b0\u898f\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u958b\u767a\u3068\u5546\u696d\u5316\u3092\u901a\u3058\u3066\u3001\u73fe\u5b9f\u4e16\u754c\u306b\u304a\u3051\u308b\u76f2\u76ee\u306e\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u306b\u53d6\u308a\u7d44\u3080\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b[\u4f01\u696d\u540d]\u306f\u672c\u65e5\u300128\u65e5\u306b\u958b\u50ac\u3055\u308c\u308b\u5b66\u4f1a\u3067\u8907\u6570\u306e\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u884c\u3046\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002<sup>\u756a\u76ee<\/sup>\u00a0\u7c73\u56fd\u907a\u4f1d\u5b50\u7d30\u80de\u6cbb\u7642\u5b66\u4f1a\u306e\u5e74\u6b21\u7dcf\u4f1a\uff08<a href=\"https:\/\/annualmeeting.asgct.org\/?gad_source=1&gad_campaignid=22011672452&gbraid=0AAAAADHZ2HQnr1TF8BjiisdZLSvQ1L5fH&gclid=Cj0KCQjwrPHABhCIARIsAFW2XBOyOPUxQcyc0OwCQ59sxmSlG0uS4eBLOykckVLfPmHO9pLdEk1Gv2waAqPOEALw_wcB\" target=\"_blank\" rel=\"nofollow noopener\">ASGCT 2025<\/a>\uff09\u3001\u30a2\u30fc\u30cd\u30b9\u30c8\u30fbN\u30fb\u30e2\u30ea\u30a2\u30eb\u30fb\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc\u3067\u958b\u50ac\u3055\u308c\u308b\u3002\u00a0<span class=\"xn-location\">\u30cb\u30e5\u30fc\u30aa\u30fc\u30ea\u30f3\u30ba<\/span>,\u00a0<span class=\"xn-chron\">5\u670813\u65e5\uff5e17\u65e5<\/span><sup>\u756a\u76ee<\/sup>, 2025\u5e74\u3002Nanoscope\u306e\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u540c\u793e\u306e\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/technology-2\/\" target=\"_blank\" rel=\"nofollow noopener\">MCO-010\u5149\u907a\u4f1d\u5b66\u7642\u6cd5<\/a>\u00a0\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308bMCO-010\u306f\u3001MCO\uff08\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u304a\u3051\u308b\u6700\u3082\u5148\u9032\u7684\u306a\u30d7\u30ed\u30b0\u30e9\u30e0\u3067\u3042\u308a\u3001\u5909\u7570\u306e\u7a2e\u985e\u3092\u554f\u308f\u306a\u3044\u6700\u521d\u3067\u552f\u4e00\u306e\u6cbb\u7642\u6cd5\u3067\u3059\u3002\u00a0<a href=\"https:\/\/www.cell.com\/molecular-therapy-family\/molecular-therapy\/fulltext\/S1525-0016(25)00205-9\" target=\"_blank\" rel=\"nofollow noopener\">\u9032\u884c\u6027\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u306b\u52b9\u679c\u304c\u3042\u308b\u3053\u3068\u304c\u793a\u3055\u308c\u3066\u3044\u308b\u3002<\/a>\u00a01\u56de\u9650\u308a\u306e\u6a19\u6e96\u7684\u306a\u785d\u5b50\u4f53\u5185\u6ce8\u5c04\u306b\u3088\u3063\u3066\u6295\u4e0e\u3055\u308c\u308b\u3002.<\/p>\n<p>\u201c\u300c\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3051\u308b\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u9ec4\u6591\u5909\u6027\u75c7\u3084\u975e\u30d2\u30c8\u970a\u9577\u985e\u30e2\u30c7\u30eb\u306b\u304a\u3051\u308b\u5730\u56f3\u72b6\u840e\u7e2e\u75c7\u306a\u3069\u3001\u8907\u6570\u306e\u7db2\u819c\u75be\u60a3\u306b\u5bfe\u3059\u308b\u5f53\u793e\u306eMCO\u7642\u6cd5\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027\u306e\u7d50\u679c\u3092\u767a\u8868\u3067\u304d\u308b\u3053\u3068\u3092\u5b09\u3057\u304f\u601d\u3044\u307e\u3059\u300d\u3068\u535a\u58eb\u306f\u8ff0\u3079\u307e\u3057\u305f\u3002.\u00a0<span class=\"xn-person\">\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3<\/span>, \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u5171\u540c\u5275\u8a2d\u8005\u517c\u793e\u9577\u3002\u201c<b>MCO-010\u306e\u6709\u52b9\u6027\u3092\u4fdd\u8a3c\u3059\u308b\u305f\u3081\u306e\u5805\u7262\u306a\u30a2\u30c3\u30bb\u30a4\u3092\u63d0\u793a\u3059\u308b\u3053\u3068\u306b\u52a0\u3048\u3066<\/b>, \u79c1\u305f\u3061\u306f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u306b\u898b\u3089\u308c\u305f\u6301\u7d9a\u7684\u306a\u6cbb\u7642\u52b9\u679c\u3068\u540c\u69d8\u306e\u80af\u5b9a\u7684\u306a\u6cbb\u7642\u52b9\u679c\u306e\u8a73\u7d30\u3092\u5171\u6709\u3067\u304d\u308b\u3053\u3068\u3092\u697d\u3057\u307f\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u00a0<b>\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u60a3\u8005\u306b\u304a\u3051\u308b\u8996\u529b\u6539\u5584\u3002.\u00a0<\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306b\u3068\u3063\u3066\u3001MCO-010\u306e\u5546\u696d\u5316\u306b\u5411\u3051\u305f\u6e96\u5099\u3001\u7279\u306b\u751f\u7269\u88fd\u5264\u627f\u8a8d\u7533\u8acb\uff08BLA\uff09\u306e\u63d0\u51fa\u6e96\u5099\u3092\u9032\u3081\u3066\u3044\u308b\u4eca\u3001\u975e\u5e38\u306b\u523a\u6fc0\u7684\u306a\u6642\u671f\u3092\u8fce\u3048\u3066\u3044\u307e\u3059\u3002\u201d<\/p>\n<p>\u4f1a\u8b70\u3067\u306e\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u3068\u304a\u308a\u3067\u3059\u3002<\/p>\n<p><a href=\"https:\/\/c212.net\/c\/link\/?t=0&l=en&o=4425505-1&h=1073963099&u=https%3A%2F%2Fannualmeeting.asgct.org%2Fprogram&a=Full+Agenda\" target=\"_blank\" rel=\"nofollow noopener\">\u5168\u8b70\u4e8b\u65e5\u7a0b<\/a><\/p>\n<p>\u58c7\u4e0a\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\uff1a<\/p>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">5\u670813\u65e5\uff08\u706b\uff09<\/span><sup>\u756a\u76ee<\/sup>, \u5348\u5f8c2\u664215\u5206 \u2013\u00a0<span class=\"xn-chron\">\u5348\u5f8c2\u664230\u5206<\/span>;\u00a0<i>265-268\u53f7\u5ba4<\/i>\u00a0<\/b>\u2013 \u535a\u58eb.\u00a0<span class=\"xn-person\">\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3<\/span>\u00a0\u3054\u7d39\u4ecb\u3059\u308b \u2013 \u300c\u201c<i>\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\u907a\u4f1d\u5b50\u6cbb\u7642\u306b\u3088\u308b\u975e\u30d2\u30c8\u970a\u9577\u985e\u5730\u56f3\u72b6\u840e\u7e2e\u30e2\u30c7\u30eb\u306b\u304a\u3051\u308b\u8996\u529b\u6539\u5584\u306e\u5b89\u5168\u6027\u3068\u6709\u52b9\u6027<\/i>\u201c<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">5\u670813\u65e5\uff08\u706b\uff09<\/span><sup>\u756a\u76ee<\/sup>,\u00a0<span class=\"xn-chron\">\u5348\u5f8c2\u664230\u5206<\/span>\u00a0\u2013\u00a0<span class=\"xn-chron\">\u5348\u5f8c2\u664245\u5206<\/span>;\u00a0<i>288-290\u53f7\u5ba4<\/i>\u00a0<\/b>\u2013 \u535a\u58eb.\u00a0<span class=\"xn-person\">\u30b5\u30a6\u30e9\u30f4\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3<\/span>\u00a0\u3054\u7d39\u4ecb\u3059\u308b \u2013 \u300c\u201c<i>\u30a2\u30d5\u30ea\u30ab\u30df\u30c9\u30ea\u30b6\u30eb\u306e\u7db2\u819c\u306b\u304a\u3051\u308b\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\u306e\u753b\u50cf\u8a98\u5c0e\u30ec\u30fc\u30b6\u30fc\u30d9\u30fc\u30b9\u975e\u30a6\u30a4\u30eb\u30b9\u6a19\u7684\u9001\u9054\u306e\u5b89\u5168\u6027\u3001\u5fcd\u5bb9\u6027\u3001\u751f\u4f53\u5185\u5206\u5e03\u3001\u907a\u4f1d\u5b50\u767a\u73fe\u304a\u3088\u3073\u6709\u52b9\u6027<\/i>\u201c<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">5\u670814\u65e5\uff08\u6c34\uff09<\/span><sup>\u756a\u76ee<\/sup>,\u00a0<span class=\"xn-chron\">\u5348\u5f8c4\u6642<\/span>\u00a0\u2013\u00a0<span class=\"xn-chron\">\u5348\u5f8c4\u664215\u5206<\/span>;\u00a0<i>265-268\u53f7\u5ba4<\/i><\/b>\u2013 \u535a\u58eb.\u00a0<span class=\"xn-person\">\u30b9\u30d6\u30e9\u30bf\u30fb\u30d0\u30bf\u30d3\u30a2\u30eb<\/span>\u00a0\u3054\u7d39\u4ecb\u3059\u308b \u2013 \u300c\u201c<i>\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u305f\u3081\u306e\u76f4\u4ea4\u52b9\u529b\u30a2\u30c3\u30bb\u30a4\u306e\u958b\u767a\uff1a\u907a\u4f1d\u5b50\u767a\u73fe\u3068\u5149\u523a\u6fc0\u6d3b\u6027<\/i>\u201c<\/li>\n<\/ul>\n<p>\u30dd\u30b9\u30bf\u30fc\u767a\u8868\uff1a<\/p>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">5\u670813\u65e5\uff08\u706b\uff09<\/span><sup>\u756a\u76ee<\/sup>,\u00a0\u00a0<span class=\"xn-chron\">\u5348\u5f8c6\u6642<\/span>\u00a0\u2013\u00a0<span class=\"xn-chron\">\u5348\u5f8c7\u664230\u5206<\/span>;\u00a0<\/b><b>\u30dd\u30b9\u30bf\u30fc\u30db\u30fc\u30eb\u00a0<\/b><b>\u2013<\/b>\u00a0\u535a\u58eb\u3002\u00a0<span class=\"xn-person\">\u30f4\u30a3\u30cb\u30c3\u30c8\u30fb\u30de\u30cf\u30b8\u30e3\u30f3<\/span>\u00a0\u767a\u8868\uff1a\u300c\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u306b\u304a\u3051\u308b\u3001\u8907\u6570\u306e\u6ce2\u9577\u306e\u5149\u306b\u611f\u53d7\u6027\u3092\u6301\u3064\u30d0\u30a4\u30aa\u30a8\u30f3\u30b8\u30cb\u30a2\u30ea\u30f3\u30b0\u5408\u6210\u30bf\u30f3\u30d1\u30af\u8cea\u306e\u30d2\u30c8\u7db2\u819c\u7d30\u80de\u3078\u306e\u9001\u9054\u300d\u3001\u30dd\u30b9\u30bf\u30fc\u756a\u53f7584<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">5\u670814\u65e5\uff08\u6c34\uff09<\/span><sup>\u756a\u76ee<\/sup>,\u00a0<span class=\"xn-chron\">\u5348\u5f8c5:30<\/span>\u00a0\u2013\u00a0<span class=\"xn-chron\">\u5348\u5f8c7\u6642<\/span>;\u00a0<\/b><b>\u30dd\u30b9\u30bf\u30fc\u30db\u30fc\u30eb\u00a0<\/b><b>\u2013<\/b>\u00a0\u535a\u58eb\u3002\u00a0<span class=\"xn-person\">\u30a2\u30df\u30fc\u30eb\u30fb\u30b7\u30f3<\/span>\u00a0\u767a\u8868\u5185\u5bb9\uff1a\u300c\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\u907a\u4f1d\u5b50\u6cbb\u7642\u85ac\u306e\u5f37\u5236\u5206\u89e3\u8a66\u9a13\u300d\u3001\u30dd\u30b9\u30bf\u30fc\u756a\u53f71380<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><b><span class=\"xn-chron\">5\u670815\u65e5\uff08\u6728\uff09<\/span><sup>\u756a\u76ee<\/sup>,\u00a0<span class=\"xn-chron\">\u5348\u5f8c5:30<\/span>\u00a0\u2013\u00a0<span class=\"xn-chron\">\u5348\u5f8c7\u6642<\/span><\/b>;\u00a0<b>\u30dd\u30b9\u30bf\u30fc\u30db\u30fc\u30eb\u00a0<\/b><b>\u2013<\/b>\u00a0\u535a\u58eb\u3002\u00a0<span class=\"xn-person\">\u30a2\u30ca\u30f3\u30bf\u30fb\u30a2\u30e4\u30ac\u30ea<\/span>\u00a0\u767a\u8868\u30c6\u30fc\u30de\uff1a\u300c\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u306b\u304a\u3051\u308b\u898f\u5236\u627f\u8a8d\u306e\u8fc5\u901f\u5316\u300d\u3001\u30dd\u30b9\u30bf\u30fc\u756a\u53f71856<\/li>\n<\/ul>\n<p>ASGCT\u4f1a\u8b70\u671f\u9593\u4e2d\u3001Nanoscope\u30c1\u30fc\u30e0\u306e\u30e1\u30f3\u30d0\u30fc\u306f\u30df\u30fc\u30c6\u30a3\u30f3\u30b0\u306b\u3082\u5bfe\u5fdc\u53ef\u80fd\u3067\u3059\u3002.<\/p>\n<p><b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066<br class=\"dnr\" \/><\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u73fe\u5728\u6cbb\u7642\u6cd5\u304c\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u3067\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u5909\u7570\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308bRESTORE\u30d5\u30a7\u30fc\u30ba2b\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u826f\u597d\u306a\u8a66\u9a13\u7d42\u4e86\u7d50\u679c\u3092\u53d7\u3051\u3066\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04945772\" target=\"_blank\" rel=\"nofollow noopener\">NCT04945772<\/a>\uff09\u3001\u540c\u793e\u306f\u3001\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/10\/10\/nanoscope-announces-plans-to-submit-bla-for-mco-010-to-treat-retinitis-pigmentosa\/\" target=\"_blank\" rel=\"nofollow noopener\">RP\u6cbb\u7642\u85acMCO-010\u306eBLA\u7533\u8acb<\/a>\u00a02025\u5e74\u306b\u3002\u540c\u793e\u306f\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u307e\u3057\u305f\uff08<a href=\"https:\/\/clinicaltrials.gov\/study\/NCT05417126\" target=\"_blank\" rel=\"nofollow noopener\">NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0<a href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/12\/nanoscope-therapeutics-announces-end-of-phase-2-meeting-with-u-s-fda-and-plan-to-initiate-a-phase-3-clinical-trial-of-mco-010-to-treat-stargardt-macular-degeneration\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>, 2025\u5e74\u306b\u3082\u3001MCO-010\u306f\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\uff08RP\uff09\u3068\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u306e\u4e21\u65b9\u3067FDA\u306e\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001\u7db2\u819c\u840e\u7e2e\u75c7\uff08GA\uff09\u5411\u3051\u306eIND\u7533\u8acb\u6e96\u5099\u304c\u6574\u3063\u305f\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054\u578bMCO-020\u3001\u304a\u3088\u3073\u30ec\u30fc\u30d0\u30fc\u5148\u5929\u6027\u9ed2\u5185\u969c\u5411\u3051\u306eAAV\u88fd\u5264\uff08IND\u7533\u8acb\u306b\u5411\u3051\u305f\u7814\u7a76\u4e2d\uff09\u304c\u542b\u307e\u308c\u307e\u3059\u3002.<\/p>\n<p><b>\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b><br class=\"dnr\" \/>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<br class=\"dnr\" \/>(817) 857-1186<br class=\"dnr\" \/><a href=\"mailto:PR@nanostherapeutics.com\" target=\"_blank\" rel=\"nofollow noopener\">PR@nanostherapeutics.com<\/a><\/p>\n<p>\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Presentations will highlight durability, efficacy and safety of\u00a0Nanoscope\u2019s optogenetic therapy platforms DALLAS,\u00a0May 12, 2025\u00a0\/PRNewswire\/ \u2014\u00a0Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative diseases, today announced multiple presentations at the 28th\u00a0annual meeting of the American Society of Gene and Cell Therapy (ASGCT 2025), to be held at the Ernest N. Morial Convention Center in\u00a0New Orleans,\u00a0May 13-17th, 2025.\u00a0 Nanoscope\u2019s presentations will be centered around the company\u2019s\u00a0MCO-010 optogenetic therapy\u00a0for retinal degenerative diseases. MCO-010 is the most advanced program in the MCO (multi-characteristic opsin) platform and the first and only mutation-agnostic therapy\u00a0shown to restore vision in [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":7181,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-7237","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-02T23:20:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-13T20:09:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting\",\"datePublished\":\"2025-07-02T23:20:55+00:00\",\"dateModified\":\"2025-07-13T20:09:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/\"},\"wordCount\":567,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/\",\"name\":\"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg\",\"datePublished\":\"2025-07-02T23:20:55+00:00\",\"dateModified\":\"2025-07-13T20:09:02+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg\",\"width\":2560,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/07\\\/02\\\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001ASGCT 2025\u5e74\u6b21\u7dcf\u4f1a\u3067\u753b\u671f\u7684\u306a\u7814\u7a76\u3092\u767a\u8868\u3078 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2025-07-02T23:20:55+00:00","article_modified_time":"2025-07-13T20:09:02+00:00","og_image":[{"width":1200,"height":242,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/06\/NSCOPE_nu_Logo_Horizontal_2Color_1200px.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting","datePublished":"2025-07-02T23:20:55+00:00","dateModified":"2025-07-13T20:09:02+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/"},"wordCount":567,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/05\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/","url":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001ASGCT 2025\u5e74\u6b21\u7dcf\u4f1a\u3067\u753b\u671f\u7684\u306a\u7814\u7a76\u3092\u767a\u8868\u3078 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/05\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg","datePublished":"2025-07-02T23:20:55+00:00","dateModified":"2025-07-13T20:09:02+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/05\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/05\/NSCOPE_ASGCT_LI_2025FEATURE-scaled-1.jpg","width":2560,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2025\/07\/02\/nanoscope-therapeutics-to-present-groundbreaking-research-at-asgct-2025-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics to Present Groundbreaking Research at ASGCT 2025 Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/7237","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=7237"}],"version-history":[{"count":1,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/7237\/revisions"}],"predecessor-version":[{"id":7559,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/7237\/revisions\/7559"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/7181"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=7237"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=7237"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=7237"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}